Overview

Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the amount of metabolites of ATL-962 in the blood and to investigate the effect of ATL-962 on the amount of fat that is excreted in the faeces in subjects who are obese
Phase:
Phase 1
Details
Lead Sponsor:
Alizyme
Treatments:
Cetilistat